Breast cancer cells can break away from the primary tumor and travel throughout the body in the blood or the lymph system. These cells can form new tumors in another part of the body. When this happens, it’s called metastases.
The University of Michigan no longer has any teams competing in STAT Madness. The team led by Costas Lyssiotis, Ph.D. made it to Round 4. We are proud of the research done at the University of Michigan and are particularly proud for those who were recognized in this national competition.
The multi-site phase Ib/II study looked at the combination of the immunotherapy drug pembrolizumab with bevacizumab for metastatic renal cell carcinoma. Pembrolizumab is known commercially as Keytruda and bevacizumab is known as Avastin.
MI-3454 resulted in complete remission in mouse models. Now, a Phase I clinical trial, using a structurally related analog of the compound, is currently enrolling patients.
Globally, especially in low- and middle-income countries in Africa, Latin America, the Caribbean and Asia, an estimated 569,847 women were diagnosed with cervical cancer in 2018, with 85% of that burden occurring in low- and middle-income countries.
A new way to cleanly separate out cancer cells from a blood sample enables comprehensive genetic profiling of the cancer cells, which could help doctors target tumors and monitor treatments more effectively.
Women with early stage breast cancer who test positive for an inherited genetic variant aren’t always receiving cancer treatment that follows current guidelines, a new study finds.
MENU